MeSH term
Frequency | Condition_Probility | Aged | 13 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Female | 54 | 0.0 |
Gene Frequency | 13 | 0.0 |
Genetic Predisposition to Disease/genetics | 2 | 0.0 |
Humans | 79 | 0.0 |
Male | 55 | 0.0 |
Middle Aged | 24 | 0.0 |
Monoamine Oxidase/*genetics | 38 | 55.0 |
*Polymorphism, Genetic | 11 | 0.0 |
Research Support, Non-U.S. Gov't | 58 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
X Chromosome | 8 | 1.0 |
Antidepressive Agents, Second-Generation/*therapeutic use | 2 | 40.0 |
Genotype | 24 | 0.0 |
Psychiatric Status Rating Scales | 5 | 2.0 |
Sex Characteristics | 3 | 0.0 |
Adolescent | 13 | 0.0 |
Adult | 31 | 0.0 |
Autopsy | 2 | 1.0 |
Comparative Study | 7 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Animals | 12 | 0.0 |
*Dosage Compensation (Genetics) | 3 | 1.0 |
Molecular Sequence Data | 12 | 0.0 |
Monoamine Oxidase/genetics | 12 | 54.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
X Chromosome/*genetics | 4 | 1.0 |
Chi-Square Distribution | 2 | 0.0 |
Gene Frequency/genetics | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Linkage Disequilibrium/genetics | 2 | 1.0 |
Polymorphism, Genetic/genetics | 3 | 0.0 |
Alleles | 25 | 0.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 11 | 0.0 |
Promoter Regions (Genetics)/*genetics | 6 | 0.0 |
DNA/genetics | 7 | 0.0 |
Minisatellite Repeats/genetics | 5 | 11.0 |
Polymorphism, Genetic | 9 | 0.0 |
*Suicide | 2 | 11.0 |
Bipolar Disorder/enzymology/*genetics | 3 | 25.0 |
Carrier Proteins/genetics | 6 | 1.0 |
Membrane Glycoproteins/genetics | 7 | 3.0 |
*Membrane Transport Proteins | 9 | 1.0 |
Minisatellite Repeats | 5 | 3.0 |
*Nerve Tissue Proteins | 7 | 1.0 |
Phenotype | 4 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
Receptors, Dopamine D2/genetics | 5 | 10.0 |
Exons | 3 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Introns | 3 | 0.0 |
*Minisatellite Repeats | 3 | 3.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Polymerase Chain Reaction | 13 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Rats | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Karyotyping | 5 | 0.0 |
Dopamine/*genetics | 2 | 15.0 |
Linkage (Genetics) | 7 | 0.0 |
Pedigree | 8 | 0.0 |
Catechol O-Methyltransferase/genetics | 3 | 10.0 |
Child | 10 | 0.0 |
Family Health | 3 | 0.0 |
Infant | 3 | 0.0 |
Tyrosine 3-Monooxygenase/genetics | 4 | 8.0 |
Bipolar Disorder/*genetics | 2 | 1.0 |
Case-Control Studies | 6 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Receptors, Serotonin/genetics | 2 | 10.0 |
Carrier Proteins/*genetics | 3 | 0.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Bipolar Disorder/genetics | 2 | 9.0 |
Depression/genetics | 2 | 28.0 |
*Promoter Regions (Genetics) | 6 | 0.0 |
Nerve Tissue Proteins/*genetics | 2 | 0.0 |
Personality/*genetics | 2 | 6.0 |
X Chromosome/genetics | 2 | 1.0 |
*Aggression | 3 | 18.0 |
Isoenzymes/genetics | 3 | 0.0 |
*Membrane Glycoproteins | 2 | 0.0 |
Parkinson Disease/*genetics | 2 | 2.0 |
Catechol O-Methyltransferase/*genetics | 3 | 3.0 |
Gene Expression/*genetics | 2 | 1.0 |
Dinucleotide Repeats/genetics | 2 | 4.0 |
Gene Expression Regulation, Enzymologic/physiology | 2 | 2.0 |
Genes, Regulator/*genetics | 2 | 4.0 |
Monoamine Oxidase/*genetics/physiology | 3 | 100.0 |
Genetic Markers | 4 | 0.0 |
Monoamine Oxidase/*genetics/metabolism | 3 | 37.0 |
Sex Factors | 5 | 0.0 |
Tandem Repeat Sequences | 2 | 1.0 |
Biological Markers | 2 | 0.0 |
Membrane Transport Proteins/genetics | 2 | 6.0 |
Nerve Tissue Proteins/genetics | 3 | 1.0 |
Serotonin/*metabolism | 2 | 4.0 |
Tryptophan Hydroxylase/genetics | 4 | 28.0 |
Base Sequence | 12 | 0.0 |
DNA Primers | 3 | 0.0 |
Mood Disorders/enzymology/*genetics | 2 | 50.0 |
Cells, Cultured | 2 | 0.0 |
Child, Preschool | 4 | 0.0 |
Risk Factors | 3 | 0.0 |
Severity of Illness Index | 2 | 0.0 |
Dosage Compensation (Genetics) | 3 | 2.0 |
Heterozygote | 2 | 0.0 |
Mental Retardation/genetics | 2 | 1.0 |
Child Abuse/*psychology | 2 | 50.0 |
Chromosome Mapping | 9 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
*X Chromosome | 12 | 1.0 |
*Linkage (Genetics) | 5 | 0.0 |
Brain/*enzymology | 2 | 1.0 |
Blindness/*genetics | 2 | 15.0 |
Syndrome | 3 | 0.0 |
Lod Score | 4 | 0.0 |
Cell Line | 3 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Monoamine Oxidase/deficiency/*genetics | 2 | 100.0 |
Retina/abnormalities | 2 | 100.0 |
*Chromosome Deletion | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Methylation | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
Genetics, Behavioral | 2 | 33.0 |
Longitudinal Studies | 2 | 0.0 |
Personality Inventory | 2 | 5.0 |
